HA
KURA icon

Harbor Advisors’s Kura Oncology KURA Stock Holding History

Harbor Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$163K – 202
2026
Q1 		$163K Buy
+20,000
New +$172K 0.02% 186
2025
Q4 		– Sell
-10,000
Closed -$88.5K – 198
2025
Q3 		$88.5K Hold
10,000
– – 0.01% 187
2025
Q2 		$57.7K Hold
10,000
– – 0.01% 188
2025
Q1 		$66K Hold
10,000
– – 0.01% 190
2024
Q4 		$87.1K Buy
+10,000
New +$144K 0.01% 187

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Harbor Advisors's KURA Position: Q2 2026 in Review

Harbor Advisors sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 20,000 shares — an estimated $163K sold.

Harbor Advisors first reported a position in KURA in Q4 2024 and held it in 5 quarters. The position peaked at $163K in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Harbor Advisors reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Harbor Advisors sold 20,000 Kura Oncology shares in Q2 2026, an estimated $163K.
  • Harbor Advisors first reported a position in Kura Oncology in Q4 2024 and held it in 5 quarters.
  • Harbor Advisors's Kura Oncology position peaked at $163K in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Harbor Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.